These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 30975165)

  • 1. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease.
    Nuzzo D; Picone P; Baldassano S; Caruana L; Messina E; Marino Gammazza A; Cappello F; Mulè F; Di Carlo M
    Curr Alzheimer Res; 2015; 12(8):723-35. PubMed ID: 26159189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauroursodeoxycholic Acid Attenuates Diet-Induced and Age-Related Peripheral Endoplasmic Reticulum Stress and Cerebral Amyloid Pathology in a Mouse Model of Alzheimer's Disease.
    Ochiai T; Nagayama T; Matsui K; Amano K; Sano T; Wakabayashi T; Iwatsubo T
    J Prev Alzheimers Dis; 2021; 8(4):483-494. PubMed ID: 34585224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
    FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
    Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice.
    Stanley M; Macauley SL; Caesar EE; Koscal LJ; Moritz W; Robinson GO; Roh J; Keyser J; Jiang H; Holtzman DM
    J Neurosci; 2016 Nov; 36(46):11704-11715. PubMed ID: 27852778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
    Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE
    Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain.
    Sano T; Ochiai T; Nagayama T; Nakamura A; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    J Neurosci; 2023 Oct; 43(43):7226-7241. PubMed ID: 37699718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.
    To AW; Ribe EM; Chuang TT; Schroeder JE; Lovestone S
    PLoS One; 2011 Feb; 6(2):e16991. PubMed ID: 21347323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the effects of ovarian hormone loss and diet-induced obesity on Alzheimer's disease markers of amyloid-β production and degradation.
    Hayward GC; Baranowski BJ; Marko DM; MacPherson REK
    J Neurophysiol; 2021 Apr; 125(4):1068-1078. PubMed ID: 33534663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer's Disease.
    Reilly AM; Tsai AP; Lin PB; Ericsson AC; Oblak AL; Ren H
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
    Moroz N; Tong M; Longato L; Xu H; de la Monte SM
    J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
    Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE
    Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model.
    Sankar SB; Infante-Garcia C; Weinstock LD; Ramos-Rodriguez JJ; Hierro-Bujalance C; Fernandez-Ponce C; Wood LB; Garcia-Alloza M
    J Neuroinflammation; 2020 Jan; 17(1):38. PubMed ID: 31992349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance.
    Herrero-Labrador R; Trueba-Saiz A; Martinez-Rachadell L; Fernandez de Sevilla ME; Zegarra-Valdivia JA; Pignatelli J; Diaz-Pacheco S; Fernandez AM; Torres Aleman I
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.